Table 5.
Iron loading parameters on CMR and laboratory tests (iron turnover, glycemia, and liver function) in patients by subgroup.
| Treatment Status | On Treatment n = 24 (57%) |
Treatment Naive n = 18 (43%) |
p |
|---|---|---|---|
| Age [years] mean ± SD (range) | 42 ± 15 (range 18–77) |
51 ± 14 (range 20–68) |
0.055 |
| Gender, N | (F = 9, M = 15) | (F = 4, M = 14) | 0.289 |
| myoT2* [ms] median (Q1–Q3) |
34 (32–37) |
33 (31–35) |
0.180 |
| myoT1 [ms] median (Q1–Q3) |
970 (946–988) |
956 (951–973) |
0.570 |
| livT2* [ms] median (Q1–Q3) |
20 (2–44) | 22 (3–44) | 0.434 |
| Iron [mcg/dL] median (Q1–Q3) |
196 (165–225) |
206 (179–252) |
0.286 |
| Ferritin [mcg/dL] median (Q1–Q3) |
421 (266–936) |
714 (368–1037) |
0.315 |
| TSAT [mcg/dL] median (Q1–Q3) |
81 (65–92) |
84 (66–95) |
0.447 |
| Haemoglobin [mcg/dL] median (Q1–Q3) |
15 (14.0–16.4) |
15.3 (14.7–16.0) |
0.716 |
| Glucose [mcg/dL] median (Q1–Q3) |
93 (85–102) |
97 (89–111) |
0.332 |
| ASPAT [mcg/dL] median (Q1–Q3) |
30 (20–39) |
34 (24–53) |
0.253 |
| ALAT [mcg/dL] median (Q1–Q3) |
39 (24–67) |
55 (34–95) |
0.143 |